drugset

drugset / Trial / NCT07468396

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

NCT07468396 ↗

Phase 1 Not yet recruiting 65 enrolled Gan & Lee Pharmaceuticals.

NaSingle-groupOpen-labelTreatment

Summary

A Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer

Timeline

Start: 2026-04-30
Primary completion: 2031-10-30
Completion: 2033-04-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GLR2037	Unknown	—	—

Indications